Data availability statement
The data that support the findings of this study are available upon
request from the corresponding author. The data are not publicly
available due to privacy or ethical restrictions.
References
- Fokkens WJ, Lund VJ, Hopkins C,
et al. European Position Paper on Rhinosinusitis and Nasal Polyps
2020. Rhinology. 2020;58(Suppl S29):1-464.
- Fujieda S, Imoto Y, Kato Y, et al. Eosinophilic chronic
rhinosinusitis. Allergol Int. 2019;68:403-412.
- Zhang N, Van Zele T, Perez-Novo V, et al. Different types of
T-effector cells orchestrate mucosal inflammation in chronic sinus
disease. J Allergy Clin Immunol . 2008;122:961-968.
- Hulse KE, Stevens WW, Tan BK, et al. Pathogenesis of nasal polyposis.Clin Exp Allergy. 2015;45:328-346.
- Tokunaga T, Sakashita M, Haruna T, et al. Novel scoring system and
algorithm for classifying chronic rhinosinusitis: the JESREC Study.Allergy . 2015;70:995-1003.
- Lund VJ, Mackay IS. Staging in rhinosinusitus. Rhinology .
1993;31:183–184
- Sedaghat AR, Gray ST, Caradonna SD, et al. Clustering of chronic
rhinosinusitis symptomatology reveals novel associations with
objective clinical and demographic characteristics. Am J Rhinol
Allergy. 2015 ;29:100-105.
- Shimizu T, Suzaki H. Past, present and future of macrolide thrapy for
chronic rhinosinusitis in Japan. Auris Nasus Larynx .
2016:43:131-136.
- Schleimer RP. Immunopathogenesis of chronic rhinosinusitis and nasal
polyposis. Annu Rev Pathol . 2017;12:331-57.
- Tojima I, Shimizu T.
Group 2 innate
lymphoid cells and eosinophilic chronic rhinosinusitis. Curr
Opin Allergy Clin Immunol. 19:18-25, 2019
- Tojima I, Kouzaki H, Shimizu S, et al.
Group 2 innate
lymphoid cells are increased in nasal polyps in patients with
eosinophilic chronic rhinosinusitis. Clin Immunol. 2016; 170:
1-8.
- Tojima I, Matsumoto K, Kikuoka H, et al. Evidence for the induction of
Th2 inflammation by group 2 innate lymphoid cells in response to
prostaglandin D2 and cysteinyl leukotrienes in allergic rhinisits.Allergy. 2019; 74: 2417-26.
- Ho J, Bailey M, Zaunders J, et al. Group 2 innate lymphoid cells
(ILC2s) are increased in chronic rhinosinusitis with nasal polyps or
eosinophilia. Clin Exp Allergy. 2015;45:394-403.
- Walford
HH, Lund
SJ, Baum
RE, et al. Increased ILC2s in the eosinophilic nasal polyp endotype
are associated with corticosteroid responsiveness. Clin
Immunol. 2014; 155:126-135.
- Eastman JJ, Cavagnero KJ, Deconde AS, et al. Group 2 innate lymphoid
cells are recruited to the nasal mucosa in patients with
aspirin-exacerbated respiratory disease. J Allergy Clin
Immunol. 2017;140:101-108.e3.
- Winkler C, Hochdörfer T, Israelsson E, et al. Activation of group 2
innate lymphoid cells after allergen challenge in asthmatic patients.J Allergy Clin Immunol. 2019;144:61-69.
- Zhong H, Fan XL, Yu QN, et al. Increased innate type 2 immune response
in house dust mite-allergic patients with allergic rhinitis.Clinical Immunol. 2017; 183:293-299.
- Lao-Araya M, Steveling E, Scadding GW, et al. Seasonal increases in
peripheral innate lymphoid type 2 cells are inhibited by subcutaneous
grass pollen immunotherapy. J Allergy Clin Immunol.2014;134(5):1193-1195.e4.
- Bartemes
KR, Kephart
GM, Fox
SJ, et al. Enhanced innate type 2 immune response in
peripheral blood from patients with asthma.J Allergy
Clin Immunol. 2014; 134:671-678.
- Jia Y, Fang X, Zhu X, et al. IL-131 Type 2 Innate Lymphoid Cells
Correlate with Asthma Control Status and Treatment Response. Am
J Respir Cell Mol Biol . 2016;l 55:675-683.
- Liu T, Wu J, Zhao J, et al. Type 2 innate lymphoid cells: A novel
biomarker of eosinophilic airway inflammation in patients with mild to
moderate asthma. Respir Med. 2015;109:1391-1396.
- Poposki JA, Klingler AI, Tan BK, et al. Group 2 innate lymphoid cells
are elevated and activated in chronic rhinosinusitis with nasal
polyps. Immun Inflamm Dis. 2017;5:233-243.
- Bachert C, Marple B, Schlosser RJ, et al. Adult chronic
rhinosinusitis. Nat Rev Dis Primers. 2020;6:86.
Table 1. Patient characteristics
Note: Data are presented as the mean ± SEM.
Abbreviations: eCRS, eosinophilic chronic rhinosinusitis; N-ERD,
nonsteroidal anti-inflammatory drug-exacerbated respiratory disease; AR,
allergic rhinitis; IgE, immunoglobulin E; JESREC, Japanese
Epidemiological Survey of Refractory Eosinophilic Rhinosinusitis;
pre-op, preoperative; LMK-CT score, Lund-Mackay computed tomography scan
score; ILC2s, group 2 innate lymphoid cells; Lin, lineage; NPs, nasal
polyps; PBMCs, peripheral blood mononuclear cells; post-op,
postoperative; M, month.
Table 2. Postoperative treatments
Abbreviations: INCS, intranasal corticosteroid; SCS, systemic
corticosteroid; NS, not significant.